ArticleAnnals of medicine and surgery (2012)2024

FDA greenlights momelotinib (Ojjaara) as the exclusive treatment for myelofibrosis patients battling anemia.

Memuna Jehanzeb et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.